4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063803
Chief Scientific Officer gave up 412 shares (to pay taxes)
- Chief Scientific Officer acquired 1,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shanler Stuart · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-18 | Exercise or conversion : show line 1 in the form | +1,450 | 269,892 | D | ||
| 2018-12-18 | Shares withheld for taxes : show line 2 in the form | −412 | $6.30 | $2,596 | 269,480 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-12-18 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,450 | 1,450 | D |
Loading xslF345X03/doc4.xml…